Of the total, 30.4% were on insulin treatment, 20.6% (n = 140) needed to self-isolate because of the COVID-19 infection in themselves or someone living with or experiencing COVID-19 like symptoms such as fever, persistent cough, difficulty breathing and loss of taste and smell. The gene discussed is INS; the disease is COVID-19.